CN104435641A - 治疗甲状腺功能亢进症的中药制剂 - Google Patents
治疗甲状腺功能亢进症的中药制剂 Download PDFInfo
- Publication number
- CN104435641A CN104435641A CN201410636943.3A CN201410636943A CN104435641A CN 104435641 A CN104435641 A CN 104435641A CN 201410636943 A CN201410636943 A CN 201410636943A CN 104435641 A CN104435641 A CN 104435641A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- medicine preparation
- traditional chinese
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 28
- 206010020850 Hyperthyroidism Diseases 0.000 title claims abstract description 23
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 239000000463 material Substances 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000007788 liquid Substances 0.000 claims description 11
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 7
- 230000033228 biological regulation Effects 0.000 claims description 2
- 238000009835 boiling Methods 0.000 claims description 2
- 239000006187 pill Substances 0.000 abstract description 5
- 239000000843 powder Substances 0.000 abstract description 5
- 238000007796 conventional method Methods 0.000 abstract description 3
- 244000179560 Prunella vulgaris Species 0.000 abstract description 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000512259 Ascophyllum nodosum Species 0.000 abstract 1
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 240000005717 Dioscorea alata Species 0.000 abstract 1
- 235000002723 Dioscorea alata Nutrition 0.000 abstract 1
- 235000008532 Dioscorea bulbifera Nutrition 0.000 abstract 1
- 241001547127 Fritillaria cirrhosa Species 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000008113 selfheal Nutrition 0.000 abstract 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 20
- 208000026435 phlegm Diseases 0.000 description 20
- 206010011224 Cough Diseases 0.000 description 17
- 230000000694 effects Effects 0.000 description 16
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 12
- 210000004072 lung Anatomy 0.000 description 11
- 210000004185 liver Anatomy 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 9
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 229940079593 drug Drugs 0.000 description 8
- 230000006870 function Effects 0.000 description 7
- 238000009826 distribution Methods 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 206010018498 Goitre Diseases 0.000 description 5
- 208000033809 Suppuration Diseases 0.000 description 5
- 206010047700 Vomiting Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 201000003872 goiter Diseases 0.000 description 5
- 201000007227 lymph node tuberculosis Diseases 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 230000008673 vomiting Effects 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 210000002216 heart Anatomy 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 208000013116 chronic cough Diseases 0.000 description 3
- 201000003453 lung abscess Diseases 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- OBIOZWXPDBWYHB-UHFFFAOYSA-N Nobiletin Natural products C1=CC(OC)=CC=C1C1=C(OC)C(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 OBIOZWXPDBWYHB-UHFFFAOYSA-N 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- MRIAQLRQZPPODS-UHFFFAOYSA-N nobiletin Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 MRIAQLRQZPPODS-UHFFFAOYSA-N 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000008700 sympathetic activation Effects 0.000 description 2
- YRCWQPVGYLYSOX-UHFFFAOYSA-N synephrine Chemical compound CNCC(O)C1=CC=C(O)C=C1 YRCWQPVGYLYSOX-UHFFFAOYSA-N 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- UYALWPKCIMKALF-YHPVUIEZSA-N (1S,3R,5S,6R,8R,10R,11S,12S)-3-(furan-3-yl)-8-hydroxy-5-methyl-14-oxo-2,13-dioxatetracyclo[10.2.1.01,5.06,11]pentadecane-10-carboxylic acid Chemical compound C[C@@]12C[C@@H](O[C@@]11C[C@H](OC1=O)[C@@H]1[C@@H](C[C@H](O)C[C@@H]21)C(O)=O)c1ccoc1 UYALWPKCIMKALF-YHPVUIEZSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 208000006029 Cardiomegaly Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- QEANLIISUSNNDX-YHPVUIEZSA-N Diosbulbin B Chemical compound C=1([C@H]2C[C@@]3([C@@]4(C(O[C@@H](C4)[C@H]4[C@H]3C[C@@H]3C[C@H]4C(O3)=O)=O)O2)C)C=COC=1 QEANLIISUSNNDX-YHPVUIEZSA-N 0.000 description 1
- UYALWPKCIMKALF-UHFFFAOYSA-N Diosbulbin C Natural products O1C2(C(OC(C2)C2C3CC(O)CC2C(O)=O)=O)C3(C)CC1C=1C=COC=1 UYALWPKCIMKALF-UHFFFAOYSA-N 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010015993 Eyelid oedema Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000003807 Graves Disease Diseases 0.000 description 1
- 208000015023 Graves' disease Diseases 0.000 description 1
- 206010067873 Hashitoxicosis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020674 Hypermetabolism Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- XUIIKFGFIJCVMT-LBPRGKRZSA-N L-thyroxine Chemical compound IC1=CC(C[C@H]([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-LBPRGKRZSA-N 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 208000007913 Pituitary Neoplasms Diseases 0.000 description 1
- 208000021738 Plummer disease Diseases 0.000 description 1
- 235000010674 Prunella vulgaris Nutrition 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010043784 Thyroiditis subacute Diseases 0.000 description 1
- DWCSNWXARWMZTG-UHFFFAOYSA-N Trigonegenin A Natural products CC1C(C2(CCC3C4(C)CCC(O)C=C4CCC3C2C2)C)C2OC11CCC(C)CO1 DWCSNWXARWMZTG-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- QEANLIISUSNNDX-UHFFFAOYSA-N diosbulbin B Natural products O1C2(C(OC(C2)C2C3CC4CC2C(O4)=O)=O)C3(C)CC1C=1C=COC=1 QEANLIISUSNNDX-UHFFFAOYSA-N 0.000 description 1
- WQLVFSAGQJTQCK-VKROHFNGSA-N diosgenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 WQLVFSAGQJTQCK-VKROHFNGSA-N 0.000 description 1
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 229960003918 levothyroxine sodium Drugs 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000030208 low-grade fever Diseases 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- -1 n-butene acyl lactone Chemical class 0.000 description 1
- 229940105623 neo-synephrine Drugs 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229960003684 oxedrine Drugs 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- SONNWYBIRXJNDC-VIFPVBQESA-N phenylephrine Chemical compound CNC[C@H](O)C1=CC=CC(O)=C1 SONNWYBIRXJNDC-VIFPVBQESA-N 0.000 description 1
- 208000010916 pituitary tumor Diseases 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 208000007884 postpartum thyroiditis Diseases 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000026498 progressive emaciation Diseases 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 208000037921 secondary disease Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 201000007540 subacute lymphocytic thyroiditis Diseases 0.000 description 1
- 201000007497 subacute thyroiditis Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗甲状腺功能亢进症的中药制剂,其特征在于,选用的原料药材及重量组分分别是:黄药子20份、夏枯草30份、佛手8份、桔梗12份、淡昆布10份、玄参24份、川贝母15份、茯苓15份、当归15份、陈皮12份。本发明药物可以采用中药制剂的常规方法制备成任何常规内服制剂。本发明药物可以采用中药制剂的常规方法制备成任何常规内服制剂。例如可以将这些原料药研成粉末混合均匀散剂冲服;可以将这些原料药一起水煎,然后浓缩煎液服用,或者把浓缩煎液浓缩成膏加工成丸剂服用。
Description
技术领域
本发明涉及中药制剂领域,具体涉及一种用于治疗甲状腺功能亢进症的中药制剂。具有滋阴健脾、软坚散结、清肝化痰的功效,治疗甲状腺功能亢进症疗效确切。
背景技术
甲状腺功能亢进症简称“甲亢”,是由于甲状腺合成释放过多的甲状腺激素,造成机体代谢亢进和交感神经兴奋,引起心悸、出汗、进食和便次增多和体重减少的病症。多数患者还常常同时有突眼、眼睑水肿、视力减退等症状。甲亢病因包括弥漫性毒性甲状腺肿(也称Graves病),炎性甲亢(亚急性甲状腺炎、无痛性甲状腺炎、产后甲状腺炎和桥本甲亢)、药物致甲亢(左甲状腺素钠和碘致甲亢)、hCG相关性甲亢(妊娠呕吐性暂时性甲亢)、和垂体TSH瘤甲亢。甲状腺激素是促进新陈代谢,促进机体氧化还原反应,代谢亢进需要机体增加进食;胃肠活动增强,出现便次增多;虽然进食增多,但氧化反应增强,机体能量消耗增多,患者表现体重减少;产热增多表现怕热出汗,个别患者出现低热;甲状腺激素增多刺激交感神经兴奋,临床表现心悸、心动过速,失眠,对周围事物敏感,情绪波动,甚至焦虑。甲亢患者长期没有得到合适治疗,会引起消瘦和甲亢性心脏病。患者消瘦常常容易患急性传染病感染致残或死亡。甲亢性心脏病引起心脏扩大,心律失常、心房纤颤和心力衰竭,患者丧失劳动力,其至死亡。
发明内容
本发明所述治疗甲状腺功能亢进症的中药制剂,具有滋阴健脾、软坚散结、清肝化痰的功效,治疗甲状腺功能亢进症疗效确切。
选用的原料药材及重量组分分别是:黄药子20份、夏枯草30份、佛手8份、桔梗12份、淡昆布10份、玄参24份、川贝母15份、茯苓15份、当归15份、陈皮12份。
本发明选取的原料中药材中,其功效和药理作用分别是:黄药子:含有黄独萜酯A(diosbulbine A)、皂甙、鞣质和淀粉。半干燥块茎含蔗糖22.5%、还原糖0.69%、淀粉2.5%、皂甙、鞣质。还含黄独素B,C与薯蓣皂甙元。【性味归经】苦、辛,凉。有小毒。【功能主治】解毒消肿,化痰散结,凉血止血。用于甲状腺肿大,淋巴结结核,咽喉肿痛,吐血,咯血,百日咳,癌肿;外用治疮疖。
夏枯草:唇形科植物夏枯草Prunella vulgaris L.的干燥果穗。【性味归经】:寒;苦、辛;归肝、胆经。【功能主治】:清火,明目,散结,消肿。用于目赤肿痛,目珠夜痛,头痛眩晕,瘰疬,瘿瘤,肿痛;甲状腺肿大,淋巴结结核,乳腺增生,高血压、高血糖、高血脂和高血粘。
佛手:性味归经:辛、苦、酸,温。归肝、脾、胃、肺经。功能主治:舒肝理气,和胃止痛,燥湿化痰。用于肝胃气滞,胸胁胀痛,胃脘痞满,食少呕吐,咳嗽痰多。
桔梗:味苦、辛,性微温。入肺经。能祛痰止咳,并有宣肺、排脓作用。【出处】:《神农本草经》。效】:宣肺、祛痰、利咽、排脓、利五脏、补气血、补五劳、养气。【主治】:咳嗽痰多、咽喉肿痛、肺痈吐脓、胸满胁痛、痢疾腹痛、 口舌生疮、目赤肿痛、小便癃闭。用于咳嗽痰多,胸闷不畅,咽痛,音哑,肺痈吐脓,疮疡脓成不溃。
淡昆布:[性味、归经]咸寒,入肝、胃、肾经。[功用]消痰软坚,利水消肿。用于瘿瘤瘰疬,水肿等症。
玄参:【性味归经】:味甘、苦、咸;性微寒。归肺,胃,肾经。【功效】:清热凉血,泻火解毒,滋阴。主治:温热病和营血、身热、烦渴、舌绛、发斑、骨蒸劳嗽、虚烦不寤、津伤便秘、目涩昏花、咽喉喉肿痛、瘰疬痰核、痈疽疮毒。
川贝母:清热润肺,化痰止咳。用于肺热燥咳,干咳少痰,阴虚劳嗽,咯痰带血。【性味归经】苦、甘,微寒。归肺、心经。【功能主治】清热润肺,化痰止咳。用于肺热燥咳,干咳少痰,阴虚劳嗽,咯痰带血。治虚劳咳嗽、吐痰咯血、心胸郁结、肺痿、肺痈、喉痹、乳痈。
茯苓:性味甘淡平,入心、肺、脾经。具有渗湿利水,健脾和胃,宁心安神的功效。能增强机体免疫功能,茯苓多糖有明显的抗肿瘤及保肝脏作用。可治小便不利,水肿胀满,痰饮咳逆,呕逆,恶阻,泄泻,遗精,淋浊,惊悸,健忘等症。茯苓之利水,是通过健运脾肺功能而达到的,与其它直接利水的中药不同。
当归:【化学成分】含基本内酯、正丁烯酰内酯、阿魏酸、烟酸、蔗糖和多种氨基酸,以及倍半萜类化合物等。【性味归经】性温,昧甘、辛。归肝、心、脾经。【功能主治】补血活血,调经止痛,润肠通便。用于血虚萎黄、眩晕心悸、月经不调、经闭痛经、虚寒腹痛、肠燥便秘、风湿痹痛、跌扑损伤、痈疽疮疡。
陈皮:陈皮含橙皮甙约8.4%,川陈皮素(nobiletin)约0.15%,另含辛 弗林(对羟福林)0.28%-2.54%。【性味】苦、辛,温。【归经】归肺、脾经。【主治功效】:理气健脾,调中,燥湿,化痰。主治脾胃气滞之脘腹胀满或疼痛、消化不良。湿浊阻中之胸闷腹胀、纳呆便溏。痰湿壅肺之咳嗽气喘。用于胸脘胀满,食少吐泻,咳嗽痰多。
以上方所选用的原料药材药性效互补,规避了药物之间配伍的相恶、相畏、相杀之选,使药物相须、相使作用显著,具有滋阴健脾、软坚散结、清肝化痰的作用,是治疗甲状腺功能亢进症的内服纯中草药组成制剂。
本发明药物可以采用中药制剂的常规方法制备成任何常规内服制剂。例如可以将这些原料药研成粉末混合均匀散剂冲服;可以将这些原料药一起水煎,然后浓缩煎液服用,或者把浓缩煎液浓缩成膏加工成丸剂服用;为了使该药物的各原料更好地发挥药效,针对某原料药进行特殊提取,如乙醇提取,这些不能用于限制本发明的保护范围。本发明的活性组分可以加入制备不同剂型时所需的各种常规辅料,如崩解剂、润滑剂、粘合剂等以常规的中药制剂方法制备成任何一种常用口服剂型,如丸剂、散剂、片剂、胶囊剂、口服液等。
本发明所述药物具有滋阴健脾、软坚散结、清肝化痰的功效,用于治疗甲状腺功能亢进症。本发明人经过反复研究,并通过临床试验的反复验证,终于找到了有更好疗效的内服药物,从而完成了本发明。临床应用是有良好的确切效果:
临床应用的基本资料及典型病例:
实施例1.焦XX,男,49岁。2006年7月10日初诊。
主诉:畏热、多汗、多食,进行性消瘦7个月,心悸5个月。
现病史:患者于2005年10月,无明显诱因的发现食量增加,大便次数随之增加,量多,便软,成形,无腹痛和脓血便。情绪急躁易怒,身体逐渐消 瘦,体重明显减轻,但饮水量没有增加,小便正常,色黄。前来就诊时,患者脉弦数,舌质红、苔黄腻,此为肝气有余,化火灼津成痰,痰气互结,致成瘿瘤。宜滋阴清肝理气,佐以化痰软坚。服本方15剂后,诸症已消,舌脉正常,病愈。
方法和有效量:黄药子20份、夏枯草30份、佛手8份、桔梗12份、淡昆布10份、玄参24份、川贝母15份、茯苓15份、当归15份、陈皮12份;取处方规定量中药材饮片,置适宜煎煮器中,加入清水适量,浸泡适宜时间,加热至沸,保持微沸状态一定时间(约25~30分钟),分离煎出液,药渣再加水适量煎煮,按规定煎煮2~3次后,合并煎出液,过滤或沉降分离煎出液供使用。
汤剂内服为主,每日早晚2次内服,每次150ml温服。汤剂则作用快而力峻,适应于病情较急重者。如病情较轻或缓者,宜为丸剂内服求其功。
具体实施方式
治疗甲状腺功能亢进症的中药制剂,选用的原料药材及重量组分分别是:黄药子20份、夏枯草30份、佛手8份、桔梗12份、淡昆布10份、玄参24份、川贝母15份、茯苓15份、当归15份、陈皮12份。
本发明药物可以采用中药制剂的常规方法制备成任何常规内服制剂。例如可以将这些原料药研成粉末混合均匀散剂冲服;可以将这些原料药一起水煎,然后浓缩煎液服用,或者把浓缩煎液浓缩成膏加工成丸剂服用。
Claims (1)
1.一种治疗甲状腺功能亢进症的中药制剂,其特征在于,选用的原料药材及重量组分分别是:黄药子20份、夏枯草30份、佛手8份、桔梗12份、淡昆布10份、玄参24份、川贝母15份、茯苓15份、当归15份、陈皮12份;
制备方法:黄药子20份、夏枯草30份、佛手8份、桔梗12份、淡昆布10份、玄参24份、川贝母15份、茯苓15份、当归15份、陈皮12份;取处方规定量中药材饮片,置适宜煎煮器中,加入清水适量,浸泡适宜时间,加热至沸,保持微沸状态一定时间(约25~30分钟),分离煎出液,药渣再加水适量煎煮,按规定煎煮2~3次后,合并煎出液,过滤或沉降分离煎出液供使用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410636943.3A CN104435641A (zh) | 2014-10-31 | 2014-10-31 | 治疗甲状腺功能亢进症的中药制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410636943.3A CN104435641A (zh) | 2014-10-31 | 2014-10-31 | 治疗甲状腺功能亢进症的中药制剂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104435641A true CN104435641A (zh) | 2015-03-25 |
Family
ID=52882902
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410636943.3A Pending CN104435641A (zh) | 2014-10-31 | 2014-10-31 | 治疗甲状腺功能亢进症的中药制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104435641A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105521293A (zh) * | 2015-12-29 | 2016-04-27 | 隋文倩 | 一种治疗甲亢肌无力的中药口服制剂及其制备方法 |
CN106138657A (zh) * | 2015-04-08 | 2016-11-23 | 汤晓芳 | 一种治疗甲亢的药物 |
-
2014
- 2014-10-31 CN CN201410636943.3A patent/CN104435641A/zh active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106138657A (zh) * | 2015-04-08 | 2016-11-23 | 汤晓芳 | 一种治疗甲亢的药物 |
CN105521293A (zh) * | 2015-12-29 | 2016-04-27 | 隋文倩 | 一种治疗甲亢肌无力的中药口服制剂及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102342992B (zh) | 一种用于治疗失眠的中药组合物及其制剂的制备方法 | |
CN103520572A (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN104958607A (zh) | 一种治疗妇女更年期灼口综合征的中药组合物及方法 | |
CN103432559B (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
CN104815037A (zh) | 一种治疗风湿蕴毒型慢性湿疹的药物及其制备方法 | |
CN104435326A (zh) | 治疗急性乳腺炎的中药制剂 | |
CN103933419A (zh) | 一种治疗脚气的中药 | |
CN103330837B (zh) | 一种治疗绝经妇女骨质疏松症的中药组合物 | |
CN102805834B (zh) | 一种治疗胃炎的药物及其制备方法 | |
CN104435641A (zh) | 治疗甲状腺功能亢进症的中药制剂 | |
CN104623376A (zh) | 用于治疗三叉神经痛的药物 | |
CN103330830A (zh) | 一种治疗咽喉肿痛的药物及其制备方法 | |
CN102949698A (zh) | 一种治疗子宫肌瘤的药物及其制备方法 | |
CN104800610A (zh) | 一种治疗帕金森病的中药制剂及其制备方法 | |
CN101239128B (zh) | 调经养颜中药组合物及其制备方法 | |
CN104352667A (zh) | 一种治疗非特异性阴道炎的药物及制备方法 | |
CN104436109A (zh) | 治疗硬皮病的中药制剂 | |
CN104474454A (zh) | 治疗胆囊结石的中药制剂 | |
CN104027430A (zh) | 一种治疗血瘀型子宫肌瘤的中药组合物 | |
CN102406913A (zh) | 一种治疗郁证的中药组合物 | |
CN104940777A (zh) | 一种治疗肝旺脾弱型经行泄泻的冲剂及其制备方法 | |
CN105456368A (zh) | 一种祛风除湿药丸及其制备方法 | |
CN105213666A (zh) | 双乌松节中药酒 | |
CN104383361A (zh) | 治疗急性传染性肝炎的中药制剂 | |
CN105687362A (zh) | 慢性痢疾活血止痢丸 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150325 |